Biotech Leaders



Biotech Leaders brings you the knowledge and experience of the best in the business. 

You can also review the Medtech Leaders and Healthtech Leaders


Biotech Leaders

Renee Aguiar-Lucander, CEO, Calliditas Therapeutics

Renee Aguiar-Lucander

CEO
Calliditas Therapeutics
Khatereh Ahmadi, Head of Search and Evaluation Team, European BD&L Hub, MSD

Khatereh Ahmadi

Head of Search and Evaluation Team, European BD&L Hub
MSD
Mehdi Ainouche, Principal, Jeito

Mehdi Ainouche

Principal
Jeito
Michael Altorfer, CEO, Swiss Biotech Association

Michael Altorfer

CEO
Swiss Biotech Association
Madeleine Armstrong, News Editor, Evaluate

Madeleine Armstrong

News Editor
Evaluate
Gwilym Attwell, Principal, Fish & Richardson

Gwilym Attwell

Principal
Fish & Richardson
Robin Bhattacherjee, CEO, Actimed Therapeutics

Robin Bhattacherjee

CEO
Actimed Therapeutics
Hubert Birner, Managing Partner, TVM Capital

Hubert Birner

Managing Partner
TVM Capital
Florian Brand, CEO, ATAI Life Sciences

Florian Brand

CEO
ATAI Life Sciences
Samana Brannigan, Head of Health Technologies, Innovate UK

Samana Brannigan

Head of Health Technologies
Innovate UK
Eduardo Bravo, CEO, EBAC (European Biotech Acquisition Corporation)

Eduardo Bravo

CEO
EBAC (European Biotech Acquisition Corporation)
Viola Bronsema, CEO, BIO Deutschland

Viola Bronsema

CEO
BIO Deutschland
Roel Bulthuis, Managing Director, INKEF Capital

Roel Bulthuis

Managing Director
INKEF Capital
Matt Cardinal, VP Strategy & Program Leadership, Halloran

Matt Cardinal

VP Strategy & Program Leadership
Halloran
Dean Chapman, Director (People + Cyber Solutions), Willis Towers Watson

Dean Chapman

Director (People + Cyber Solutions)
Willis Towers Watson
Paolo Cionini, Chief Commercial Officer, Almirall

Paolo Cionini

Chief Commercial Officer
Almirall
Jean-Philippe Combal, CEO, Vivet Therapeutics

Jean-Philippe Combal

CEO
Vivet Therapeutics
Yuehua Cong, Executive Director, Head of Europe, Simcere Pharmaceutical Group

Yuehua Cong

Executive Director, Head of Europe
Simcere Pharmaceutical Group
Maria Dahl, COO and Head of Europe, Innovent Bio

Maria Dahl

COO and Head of Europe
Innovent Bio
John Dawson, CEO, Oxford BioMedica

John Dawson

CEO
Oxford BioMedica
Lucas de Breed, Founder, August

Lucas de Breed

Founder
August
Ros Deegan, CEO, OMass Therapeutics

Ros Deegan

CEO
OMass Therapeutics
Louise Farley, Partner, Deepbridge Capital

Louise Farley

Partner
Deepbridge Capital
Jason Foster, CEO, Ori Biotech

Jason Foster

CEO
Ori Biotech
Chris Garabedian, Chairman and CEO, Xontogeny

Chris Garabedian

Chairman and CEO
Xontogeny
Andrew Hack, Managing Director, Bain Capital Life Sciences

Andrew Hack

Managing Director
Bain Capital Life Sciences
Alex Hamilton, Partner, Syncona

Alex Hamilton

Partner
Syncona
Deborah Harland, Partner, SR One

Deborah Harland

Venture Partner
SROne
Bill Haynes, Head of Novo Nordisk Research Centre Oxford, Novo Nordisk

Bill Haynes

Head of Novo Nordisk Research Centre Oxford
Novo Nordisk
Olav Hellebo, CEO, ReNeuron Group

Olav Hellebo

CEO
ReNeuron
William Hicks, Co-chair Securities & Capital Markets Group, Mintz

William Hicks

Co-chair Securities & Capital Markets Group
Mintz
Ben Hohn, Principal - Pharmaceuticals & Biotech, Emerging Pharma Lead, ZS Associates

Ben Hohn

Principal - Pharmaceuticals & Biotech, Emerging Pharma Lead
ZS Associates
Anne Horgan, Partner, Cambridge Innovation Capital

Anne Horgan

Partner
Cambridge Innovation Capital
Sofia Ioannidou, Partner, Andera Partners

Sofia Ioannidou

Partner
Andera Partners
Wouter Joustra, General Partner, Forbion 300x

Wouter Joustra

General Partner
Forbion
Pierre-Louis Joffrin, CDO, Mogrify

Pierre-Louis Joffrin

CDO
Mogrify
Markus Kalousek, Global Head Search & Evaluation, Novartis

Markus Kalousek

Global Head Search & Evaluation
Novartis
Maya Khurana, Health and Life Sciences Director, Oliver Wyman

Maya Khurana

Health and Life Sciences Director
Oliver Wyman
Sven Kili, CEO, Antion

Sven Kili

CEO
Antion
Dima Kuzmin, Managing Director, 4BIO Capital

Dima Kuzmin

Managing Director
4BIO Capital
Werner Lanthaler, CEO, Evotec

Werner Lanthaler

CEO
Evotec
Marta Helena Lesko, Head of BD Enabling Technologies, Merck KGaA

Marta Helena Lesko

Head of BD Enabling Technologies
Merck KGaA
Peter Llewellyn-Davies, CEO, APEIRON

Peter Llewellyn-Davies

CEO
APEIRON
Nicoletta Loggia, CTO, Orchard Therapeutics

Nicoletta Loggia

CTO
Orchard Therapeutics
Philippe Lopes Fernandes, CBO, Ipsen

Philippe Lopes Fernandes

CBO
Ipsen
Tim Luker, VP Venture Science, Corporate BD, Eli Lilly

Tim Luker

VP Venture Science, Corporate BD
Eli Lilly
Gavin MacGregor, Investment Advisor Public Equity, HBM Partners

Gavin MacGregor

Investment Advisor Public Equity
HBM Partners
Priya Mande, CEO, PsiOxus Therapeutics

Priya Mande

CEO
PsiOxus Therapeutics
Dan Marshall, Director Business Development, MSD

Dan Marshall

Director Business Development
MSD
Mark McCarthy, Executive Director, Human Genetics; Senior Fellow, Genentech

Mark McCarthy

Executive Director, Human Genetics; Senior Fellow
Genentech
Robbie McLaren, Partner and Vice Chair of the Global Life Sciences Practice, Latham & Watkins

Robbie McLaren

Partner and Vice Chair of the Global Life Sciences Practice
Latham & Watkins
Jason Mellad, CEO, Start Codon

Jason Mellad

CEO
Start Codon
Elizabeth Mily, EVP Strategy & BD, Bristol Myers Squibb

Elizabeth Mily

EVP Strategy & BD
Bristol Myers Squibb
Berndt Modig, CEO, Pharvaris

Berndt Modig

CEO
Pharvaris
Jukka Muhonen, Global BD & Alliances, Orion Pharma

Jukka Muhonen

Global BD & Alliances
Orion Pharma
Matthias Müllenbeck, SVP, Head Global BD & Alliance Management, Merck KGaA

Matthias Müllenbeck

, SVP, Head Global BD & Alliance Management
Merck KGaA
Karl Nägler, Managing Partner, Wellington Partners

Karl Nägler

Managing Partner
Wellington Partners
Geraldine O’Keeffe, Partner Public Equities, LSP

Geraldine O’Keeffe

Partner Public Equities
LSP
John Orwin, CEO, Atreca

John Orwin

CEO
Atreca
Tej Panesar, Investment Director, Life Sciences, British Patient Capital

Tej Panesar

Investment Director, Life Sciences
British Patient Capital
Rebecca Pope (she/her), UK Digital & Data Science Innovation Lead, Roche

Rebecca Pope (she/her)

UK Digital & Data Science Innovation Lead
Roche UK
Cody Powers, Principal - Portfolio & Pipeline, ZS Associates

Cody Powers

Principal - Portfolio & Pipeline
ZS Associates
Brad Robling, VP Corporate Business Development, Eli Lilly

Brad Robling

VP Corporate Business Development
Eli Lilly
Kieran Rooney, VP, Strategic Alliances and Licensing, Amryt Pharma

Kieran Rooney

VP, Strategic Alliances and Licensing
Amryt Pharma
Christina Rossi, Chief Commercial Officer, Blueprint Medicines

Christina Rossi

Chief Commercial Officer
Blueprint Medicines
Anya Roy, Head of Seed Investments & Technology, Illumina Accelerator

Anya Roy

Head of Seed Investments & Technology
Illumina Accelerator
Ed Saltzman, Executive Chairman at Cello Health BioConsulting

Ed Saltzman

Executive Chairman
Cello Health BioConsulting
Isabella Schidrich, Senior Managing Director, Nasdaq

Isabella Schidrich

Senior Managing Director
Nasdaq
Graziano Seghezzi, Managing Partner, Sofinnova

Graziano Seghezzi

Managing Partner
Sofinnova
Nigel Sheail, Global Head of M&A and BD&L, Novartis

Nigel Sheail

Global Head of M&A and BD&L
Novartis
Tom Shepherd, CEO, Captor Therapeutics

Tom Shepherd

CEO
Captor Therapeutics
João Siffert, CEO & President, Design Therapeutics

João Siffert

CEO & President
Design Therapeutics
Stephanie Sirota, Partner and CBO, RTW Investments

Stephanie Sirota

Partner and CBO
RTW Investments
Ulrica Slåne Bjerke, CIO, Arctic Aurora LifeScience

Ulrica Slåne Bjerke

CIO
Arctic Aurora LifeScience
Sander Slootweg, Managing Partner, Forbion

Sander Slootweg

Managing Partner
Forbion
Laurie Smaldone Alsup, CMO/CSO, NDA Group

Laurie Smaldone Alsup

CMO/CSO
NDA Group
Rhoda Steel, Head of Community Impact, Johnson & Johnson UK

Rhoda Steel

Head of Community Impact
Johnson & Johnson UK
Anette Steenberg, CEO, Medicon Valley Alliance

Anette Steenberg

CEO
Medicon Valley Alliance
Jacob Sten Petersen, Corporate VP, Head of Stem Cell R&D, Novo Nordisk

Jacob Sten Petersen

Corporate VP, Head of Stem Cell R&D
Novo Nordisk
Dick Sundh, VP, Marketing & Head of Australia, Canada and Europe (ACE), Kite Pharma

Dick Sundh

VP, Head of Australia, Canada & Europe
Kite
Steffen Thirstrup, Advisory Board Director, NDA Group

Steffen Thirstrup

Advisory Board Director
NDA Group
Diana Torgersen, Senior Associate, Novo Seeds

Diana Torgersen

Senior Associate
Novo Seeds
Erik van den Berg, CEO, AM Pharma

Erik van den Berg

CEO
AM Pharma
Edward van Wezel, Managing Partner, BGV

Edward van Wezel

Managing Partner
BGV
Bonnie Van Wilgenburg, Principal, Monograph Capital Partners

Bonnie Van Wilgenburg

Principal
Monograph Capital Partners
Valerie Vanhooren, CEO, ONA Therapeutics

Valerie Vanhooren

CEO
ONA Therapeutics
Guillaume Vignon, SVP BD, Beigene

Guillaume Vignon

SVP BD
Beigene
Pnina Weitz, Global Head of VC Business Development & Relationship Management, Lonza

Pnina Weitz

Global Head of VC Business Development & Relationship Management
Lonza
Anna Williamson, Executive Director, Roche Pharma Partnering

Anna Williamson

Executive Director
Roche Pharma Partnering
Donald Xu, Managing Partner, Lynx Financial

Don Xu

Managing Director
Lynx Capital
Alexandra Zemp, Partner, McKinsey

Alexandra Zemp

Partner
McKinsey
Mai-Britt Zocca, CEO, IO Biotech

Mai-Britt Zocca

CEO
IO Biotech
DOWNLOAD BROCHURE